CDKN2A and hepatocellular carcinoma: After systematically exploring the differentially expressed genes related to immunity in hepatocellular carcinoma, Luo et al. [64] concluded that the high expression of cdkn2a is associated with a poor prognosis of hepatocellular carcinoma and a decrease in immune infiltration.